Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Update on alefacept safety
Denise Wexler, Gordon Searles, Ian Landells, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
Hermenio Lima, Melinda Gooderham, Jan Dutz, et al.
Journal of Cutaneous Medicine and Surgery
|
November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
Acta Dermato-Venereologica
|
October 18, 2019
Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, et al.
Journal of Cutaneous Medicine and Surgery
|
May 4, 2005
Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004
Lyn Guenther, Richard G Langley, Neil H Shear, et al.
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
June 23, 2017
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
Afsaneh Alavi, Charles Lynde, Raed Alhusayen, et al.
Journal of the American Academy of Dermatology
|
April 17, 2018
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)
Alice B Gottlieb, Andrew Blauvelt, Diamant Thaçi, et al.
Journal of the American Academy of Dermatology
|
March 19, 2011
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study
Bruce E Strober, Yves Poulin, Francisco A Kerdel, et al.
Frontiers in Medicine
|
March 31, 2022
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II
Stephanie Ghazal, Zainab Ridha, Kathleen D'Aguanno, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Update on alefacept safety
Denise Wexler, Gordon Searles, Ian Landells, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
Hermenio Lima, Melinda Gooderham, Jan Dutz, et al.
Journal of Cutaneous Medicine and Surgery
|
November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
Acta Dermato-Venereologica
|
October 18, 2019
Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, et al.
Journal of Cutaneous Medicine and Surgery
|
May 4, 2005
Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004
Lyn Guenther, Richard G Langley, Neil H Shear, et al.
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Journal of Cutaneous Medicine and Surgery
|
June 23, 2017
Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
Afsaneh Alavi, Charles Lynde, Raed Alhusayen, et al.
Journal of the American Academy of Dermatology
|
April 17, 2018
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)
Alice B Gottlieb, Andrew Blauvelt, Diamant Thaçi, et al.
Journal of the American Academy of Dermatology
|
March 19, 2011
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study
Bruce E Strober, Yves Poulin, Francisco A Kerdel, et al.
Frontiers in Medicine
|
March 31, 2022
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II
Stephanie Ghazal, Zainab Ridha, Kathleen D'Aguanno, et al.
Page
of 11